Skip to content
  • Instagram
  • YouTube
  • X

PharmaBR.News

  • About Us

radiopharmaceuticals

  • Promising prostate cancer drug not yet available in Brazil’s SUS despite extended survival benefit
    25 de November de 2025

    Promising prostate cancer drug not yet available in Brazil’s SUS despite extended survival benefit

    pietrorubin

Categories

Reviews.

News.

Guides.

Deals.

Videos.

Reader Poll.

Features.

Staff Picks.

Game Culture.

Podcast.

At PharmaBR.News, we highlight key developments in Brazil’s pharmaceutical and health policy landscape.

Get our free weekly briefing straight to your inbox.

  • Instagram
  • YouTube
  • X
  • About Us

Designed with WordPress

Loading Comments...